ASE Announces Launch of New CASE Online Journal
/
Date31 Oct 2016
MORRISVILLE, N.C., Oct. 31, 2016 (GLOBE NEWSWIRE) — The American Society of Echocardiography (ASE) announces the launch of CASE – an online, open-access, cardiovascular imaging... Read More →
Impact of Chronic Conditions Varies Significantly Across Europe
/
Date31 Oct 2016
NEW YORK, Oct. 31, 2016 (GLOBE NEWSWIRE) — Patients with chronic diseases in Europe experience losses in quality of life that vary significantly by country,... Read More →
MailMyPrescriptions.com Earns Coveted LegitScript Certification
/
Date31 Oct 2016
BOCA RATON, Fla., Oct. 31, 2016 (GLOBE NEWSWIRE) — MailMyPrescriptions.com announced today that it had crossed a major milestone, earning certification from LegitScript. LegitScript’s pharmacy... Read More →
FibroGen Completes Enrollment in Roxadustat Phase 3 Studies in China
/
Date31 Oct 2016
SAN FRANCISCO, Oct. 31, 2016 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ:FGEN), a research-based biopharmaceutical company, today reported completion of enrollment in its Phase 3 clinical... Read More →
Dr. Edmond Bedrossian Named Honorary Member of the American College of Prosthodontists
/
Date31 Oct 2016
CHICAGO, Oct. 31, 2016 (GLOBE NEWSWIRE) — Edmond Bedrossian, DDS, has been named an Honorary Member of the American College of Prosthodontists (ACP). He was... Read More →
Intra-Cellular Therapies Presents the ITI-007 Clinical Development Program in Schizophrenia at the CNS Summit 2016 Annual Conference
/
Date31 Oct 2016
NEW YORK, Oct. 31, 2016 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) today announced presentation (in oral and poster forms) of results from its clinical... Read More →
TESARO Announces Presentation of Niraparib Data at the 2016 IGCS Biennial Meeting
/
Date31 Oct 2016
WALTHAM, Mass., Oct. 31, 2016 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced the presentation of data from the ENGOT-OV16/NOVA trial... Read More →
Mateon Announces Presentation of CA4P Posters at Meeting of the International Gynecologic Cancer Society
/
Date31 Oct 2016
– Patients with Measurable Disease Showed Significantly Improved Progression-Free Survival – – Progression-Free Survival Improved by 6.2 Months for Patients with Larger Tumors – SOUTH... Read More →
Aclaris Therapeutics Submits Investigational New Drug Application for ATI-50001 to Treat Alopecia Universalis and Alopecia Totalis
/
Date31 Oct 2016
MALVERN, Pa., Oct. 31, 2016 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ:ACRS), today announced that it has submitted an Investigational New Drug Application (IND) to... Read More →
Caladrius Biosciences Begins Enrollment of Second Cohort of Phase 2 Trial of CLBS03 as a Treatment for Type 1 Diabetes Following Favorable Safety Data from First Cohort
/
Date31 Oct 2016
Earlier assessment of clinical safety permits acceleration of trial timeline Sanford Research to Provide Operational Support at its Clinical Sites for Remainder of Trial BASKING... Read More →